July 3, 2024
Investors

Are Investors Undervaluing Ebusco Holding N.V. (AMS:EBUS) By 43%?

Key Insights The projected fair value for Ebusco Holding is €2.91 based on 2 Stage Free Cash Flow to Equity Current share price of €1.66 suggests Ebusco Holding is potentially 43% undervalued Our fair value estimate is 52% lower than Ebusco Holding’s analyst price target of €6.03 Today we’ll do a simple run through of

Read More
Investors

Are Investors Undervaluing Wallbox N.V. (NYSE:WBX) By 39%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Wallbox fair value estimate is US$2.54 Wallbox’s US$1.54 share price signals that it might be 39% undervalued The €3.43 analyst price target for WBX is 35% more than our estimate of fair value How far off is Wallbox N.V. (NYSE:WBX) from its intrinsic value?

Read More
Investors

Are Investors Undervaluing Regis Healthcare Limited (ASX:REG) By 34%?

Key Insights The projected fair value for Regis Healthcare is AU$6.08 based on 2 Stage Free Cash Flow to Equity Regis Healthcare’s AU$4.03 share price signals that it might be 34% undervalued Our fair value estimate is 52% higher than Regis Healthcare’s analyst price target of AU$4.00 How far off is Regis Healthcare Limited (ASX:REG)

Read More
Investors

Are Investors Undervaluing DXN Holdings Bhd. (KLSE:DXN) By 43%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, DXN Holdings Bhd fair value estimate is RM1.09 Current share price of RM0.63 suggests DXN Holdings Bhd is potentially 43% undervalued Our fair value estimate is 23% higher than DXN Holdings Bhd’s analyst price target of RM0.89 Today we will run through one way

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline